Daily non-political popular news in brief.

Setting the Stage to Find Drugs Against SARS

11-17-2006 · Brookhaven National Laboratory

Scientists at Brookhaven have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002. Researchers from Brookhaven's biology department and the National Synchrotron Light Source characterized a component of the virus that will be the target of new anti-SARS virus drugs.

Keywords: setting, stage, drugs, sars, drug, sar

« Previous | Next »

Similar news on "Setting the Stage to Find Drugs Against SARS":

Setting the Stage to Find Drugs Against SARS
11-14-2006 · Brookhaven National Laboratory
Scientists at Brookhaven have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002. Researchers from Brookhaven's biology department and the National Synchrotron Light Source characterized a component of the virus that will be the target of new anti-SARS virus drugs.
Similar news · Read more »
Existing drugs show promise for treating end-stage renal disease in lupus
11-09-2007 · EurekAlert!
Studies in mice suggest that two drugs already approved by the US Food and Drug Administration show promise for treating the complications of lupus, according to Nilamadham Mishra, MD, in presentations this week at the American College of Rheumatology in Boston.
Similar news · Read more »
Molecular differences between early and advanced melanomas could provide new drug targets
03-12-2007 · EurekAlert!
The cell-signaling molecule Akt is a primary trigger that leads malignant melanomas on the skin's surface to begin growing vertically beneath the skin and turn into deadly invasive cancers, scientists have found. Understanding this key molecular difference between radial melanomas that spread on the surface of the skin and melanomas that grow vertically and invasively could provide new targets for the development of drugs to treat individuals with advanced stage melanomas.
Similar news · Read more »
Gene Signatures Match Cancer And Other Diseases With Potentially Effective Drugs
09-29-2006 · ScienceDaily
In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language based on cells' distinctive gene activity profiles, or "signatures."
Similar news · Read more »
Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients
10-12-2006 · ScienceDaily
By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
Similar news · Read more »
The Journal of Clinical Pharmacology looks at effects of smoking cessation drug, 'Varenicline'
10-31-2006 · EurekAlert!
Smoking is the world's leading cause of premature death. Smokers who quit are able to significantly reduce their risk of premature death and other health issues -- almost completely if they quit by age thirty and by fifty percent if they quit after age fifty. Because it's so difficult to quit smoking, many are turning to smoking cessation drugs, such as varenicline, to help minimize cravings and other withdrawal symptoms.
Similar news · Read more »
Study suggests some drug resistance to influenza B medications
04-03-2007 · EurekAlert!
Use of certain common antiviral drugs during a recent influenza B epidemic in Japan showed the development of viruses with partial resistance to the drugs, according to a study in the April 4 issue of JAMA.
Similar news · Read more »
Drugs users are increasingly more cautious with needles
05-14-2007 · EurekAlert!
Even though HIV can be well treated these days, drug users are still more cautious about using needles than they used to be. That is the conclusion of Colette Smit following her study into 25 years of HIV in the Netherlands.
Similar news · Read more »
Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
06-27-2007 · EurekAlert!
Polymeric nanoparticles are excellent carriers for delivering drugs. However, they are quickly removed from the blood, sometimes in minutes, rendering them ineffective in delivering drugs. This study reports that nanoparticles can be forced to remain in circulation by attaching to red blood cells. Prolonged circulation of nanoparticles in the blood may potentially open new opportunities for the treatment of conditions such as cancer and heart disease.
Similar news · Read more »
MIT model could predict cells' response to drugs
07-30-2007 · EurekAlert!
MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices and drug developers identify the ideal compound. In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including cancer, arthirtis, and immune system disorders.
Similar news · Read more »